ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Metastatic Melanoma Patients May Benefit From Beta Blockers – Cancer Network

Metastatic Melanoma Patients May Benefit From Beta BlockersCancer NetworkBeta blockers appear to affect immune cells and improve immune function, and now investigators are reporting that beta blockers may play an important role in boosting immunotherap… Continue reading

2018-01-23 Michael Zand NEWS

AnGes Submits Application for Marketing Approval to PMDA for HGF gene therapy for Critical Limb Ischemia – GlobeNewswire (press release)

AnGes Submits Application for Marketing Approval to PMDA for HGF gene therapy for Critical Limb IschemiaGlobeNewswire (press release)TOKYO, Jan. 23, 2018 (GLOBE NEWSWIRE) — AnGes, Inc., a biopharmaceutical company focused on developing innovative gene… Continue reading

2018-01-23 Michael Zand NEWS

Singapore Announces Synthetic Medicinal Cannabinoids Research – Dope Magazine

Continue reading

2018-01-23 Michael Zand NEWS

Santa Clarita Woman Needs Rare Stem Cell Transplant After Lupus Diagnosis – KHTS Radio

KHTS RadioSanta Clarita Woman Needs Rare Stem Cell Transplant After Lupus DiagnosisKHTS RadioAnd while Rose remains optimistic, her doctor has recently informed her that the best plan moving forward in terms of her treatment would be to receive a Hemat… Continue reading

2018-01-23 Michael Zand NEWS

Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism–ICYMI – TheStreet.com

TheStreet.comImmunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism–ICYMITheStreet.comThe merger sent shockwaves through the immunotherapy space, as shares of Boston-based Ziopharm Oncology (ZIOP – Get Report) , San Diego-based Fat… Continue reading

2018-01-23 Michael Zand NEWS

Sublingual Allergy Immunotherapy Market – Global Industry Growth, Trends and Forecast 2017 to 2025 – Digital Journal

Sublingual Allergy Immunotherapy Market – Global Industry Growth, Trends and Forecast 2017 to 2025Digital JournalAlbany, NY — (SBWIRE) — 01/22/2018 — Sublingual allergy immunotherapy used in the treatment of allergy. It is associated with retention … Continue reading

2018-01-23 Michael Zand NEWS

Vaccine Fails to Help CMV-Positive Stem-Cell Recipients – Managed Care magazine


Dope Magazine

Singapore Announces Synthetic Medicinal Cannabinoids Research
Dope Magazine
Singapore Announces Synthetic Medicinal Cannabinoids Research The five-year program announced by Singapore’s National Research Foundation (NRF) is part of a $25 million-dollar program targeting Synthetic Biology Research Development. The program will …

Continue reading

2018-01-22 Michael Zand NEWS

Vaccine Fails to Help CMV-Positive Stem-Cell Recipients – Managed Care magazine


FiercePharma

Vaccine Fails to Help CMV-Positive Stem–Cell Recipients
Managed Care magazine
ASP0113 (Astellas Pharma Inc./ Vical Incorporated), an investigational DNA vaccine being developed for cytomegalovirus (CMV)-seropositive hematopoietic stem cell transplant recipients, did not significantly improve overall mortality and CMV end-organ …
Vical’s Astellas-partnered CMV vaccine falls short again, this time in stem cell transplant recipientsFiercePharma
CMV Vaccine Falls Short in Phase III TrialOncLive

all 4 news articles »

Continue reading

2018-01-22 Michael Zand NEWS
  • 1
  • …
  • 631
  • 632
  • 633
  • 634
  • 635
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

FiercePharma

Vaccine Fails to Help CMV-Positive Stem–Cell Recipients
Managed Care magazine
ASP0113 (Astellas Pharma Inc./ Vical Incorporated), an investigational DNA vaccine being developed for cytomegalovirus (CMV)-seropositive hematopoietic stem cell transplant recipients, did not significantly improve overall mortality and CMV end-organ …
Vical’s Astellas-partnered CMV vaccine falls short again, this time in stem cell transplant recipientsFiercePharma
CMV Vaccine Falls Short in Phase III TrialOncLive

all 4 news articles »